2460751-66-8
Chemical Structure
Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH
- CAS No.: 2460751-66-8
- Formula:C66H105N5O16
- Molecular Weight:1224.56
InChIKey: YWLOWAZATOAHDO-KKQLDWOFSA-N
SMILES: CC(C)(C)OC(CCCCCCCCCCCCCCCCCCC(N[C@@H](C(OC(C)(C)C)=O)CCC(NCCOCCOCC(NCCOCCOCC(NCCCC[C@@H](C(O)=O)NC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)=O)=O)=O)=O)=O
Biological Activity: Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH is a drug intermediate in the synthesis of Tirzepatide. Tirzepatide is a dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor (GLP-1R) agonist[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH | 99.31% | Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH is a drug intermediate in the synthesis of Tirzepatide. Tirzepatide is a dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor (GLP-1R) agonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||